Ciprofol Ameliorates Myocardial Ischemia/Reperfusion Injury by Inhibiting Ferroptosis Through Upregulating HIF-1α DOI Creative Commons

Jun Ding,

Biying Wang, Yufan Yang

и другие.

Drug Design Development and Therapy, Год журнала: 2024, Номер Volume 18, С. 6115 - 6132

Опубликована: Дек. 1, 2024

Ciprofol is a novel intravenous anesthetic that has been increasingly used in clinical anesthesia and sedation. Studies suggested ciprofol reduced oxidative stress inflammatory responses to alleviate cerebral ischemia/reperfusion (I/R) injury, but whether protects the heart against I/R injury mechanisms are unknown. Herein, we assessed effects of on ferroptosis during myocardial injury.

Язык: Английский

Ferroptosis in cardiovascular disease: regulatory mechanisms and therapeutic implications DOI

Yiheng Zhao,

Andreas Linkermann, Masafumi Takahashi

и другие.

European Heart Journal, Год журнала: 2025, Номер unknown

Опубликована: Май 21, 2025

Ferroptosis, an iron-dependent form of regulated cell death, has been identified as a key factor in the pathogenesis and progression various cardiovascular diseases (CVDs). The molecular basis ferroptosis involves lipid peroxidation, iron dysregulation, antioxidant pathways. Accumulating evidence suggests that is associated with CVDs, including atherosclerosis, myocardial ischaemia-reperfusion injury, cardiac hypertrophy, diverse cardiomyopathies. In addition to inhibitors, several novel ferroptosis-targeting therapies have emerged, new uses for existing drugs, plant-derived compounds, targeted drug delivery. This review synthesizes current knowledge, identifies research gaps summarize complex regulatory mechanisms ferroptosis, provides overview its functions CVDs. innovative therapeutic strategies targeting may lead paradigm change treatment

Язык: Английский

Процитировано

0

Collagen Glycation-Mediated Mechanical Stress Aggravates Ischemia-Reperfusion injury DOI
Jing Yang, Yixuan Li,

Xiaoxiao Fan

и другие.

Acta Biomaterialia, Год журнала: 2025, Номер unknown

Опубликована: Июнь 1, 2025

Язык: Английский

Процитировано

0

Cardiac-targeted and ROS-responsive liposomes containing puerarin for attenuating myocardial ischemia-reperfusion injury DOI
Yan Wang, Shengnan Li, Wenqun Li

и другие.

Nanomedicine, Год журнала: 2024, Номер unknown, С. 1 - 21

Опубликована: Сен. 24, 2024

This study aimed to construct an ischemic cardiomyocyte-targeted and ROS-responsive drug release system reduce myocardial ischemia-reperfusion injury (MI/RI).

Язык: Английский

Процитировано

2

Ferroptosis in Cardiovascular Diseases and Ferroptosis-Related Intervention Approaches DOI
Xiaoyang Zhou, Hao Wang, Biao Yan

и другие.

Cardiovascular Drugs and Therapy, Год журнала: 2024, Номер unknown

Опубликована: Дек. 6, 2024

Язык: Английский

Процитировано

2

Ciprofol Ameliorates Myocardial Ischemia/Reperfusion Injury by Inhibiting Ferroptosis Through Upregulating HIF-1α DOI Creative Commons

Jun Ding,

Biying Wang, Yufan Yang

и другие.

Drug Design Development and Therapy, Год журнала: 2024, Номер Volume 18, С. 6115 - 6132

Опубликована: Дек. 1, 2024

Ciprofol is a novel intravenous anesthetic that has been increasingly used in clinical anesthesia and sedation. Studies suggested ciprofol reduced oxidative stress inflammatory responses to alleviate cerebral ischemia/reperfusion (I/R) injury, but whether protects the heart against I/R injury mechanisms are unknown. Herein, we assessed effects of on ferroptosis during myocardial injury.

Язык: Английский

Процитировано

2